India · Delayed Price · Currency is INR Mangalam Drugs & Organics Statistics
Total Valuation
BOM:532637 has a market cap or net worth of INR 704.83 million. The enterprise value is 1.69 billion.
| Market Cap | 704.83M |
| Enterprise Value | 1.69B |
Important Dates
The last earnings date was Thursday, January 15, 2026.
| Earnings Date | Jan 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:532637 has 15.83 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 15.83M |
| Shares Outstanding | 15.83M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 26.31% |
| Owned by Institutions (%) | n/a |
| Float | 6.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| PB Ratio | 0.55 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.45 |
| EV / Sales | 0.71 |
| EV / EBITDA | 31.02 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.80 |
| Debt / EBITDA | 18.67 |
| Debt / FCF | n/a |
| Interest Coverage | -1.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -7.32% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 7.72% |
| Revenue Per Employee | 4.95M |
| Profits Per Employee | -644,181 |
| Employee Count | 480 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -27.45M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.39% in the last 52 weeks. The beta is -0.08, so BOM:532637's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | -50.39% |
| 50-Day Moving Average | 35.34 |
| 200-Day Moving Average | 67.42 |
| Relative Strength Index (RSI) | 61.83 |
| Average Volume (20 Days) | 96,307 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532637 had revenue of INR 2.38 billion and -309.21 million in losses. Loss per share was -19.53.
| Revenue | 2.38B |
| Gross Profit | 897.36M |
| Operating Income | -165.14M |
| Pretax Income | -336.66M |
| Net Income | -309.21M |
| EBITDA | 33.77M |
| EBIT | -165.14M |
| Loss Per Share | -19.53 |
Balance Sheet
The company has 33.78 million in cash and 1.01 billion in debt, with a net cash position of -980.89 million or -61.97 per share.
| Cash & Cash Equivalents | 33.78M |
| Total Debt | 1.01B |
| Net Cash | -980.89M |
| Net Cash Per Share | -61.97 |
| Equity (Book Value) | 1.28B |
| Book Value Per Share | 80.58 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 37.76%, with operating and profit margins of -6.95% and -13.01%.
| Gross Margin | 37.76% |
| Operating Margin | -6.95% |
| Pretax Margin | -14.17% |
| Profit Margin | -13.01% |
| EBITDA Margin | 1.42% |
| EBIT Margin | -6.95% |
| FCF Margin | n/a |
Dividends & Yields
BOM:532637 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.08% |
| Shareholder Yield | -0.08% |
| Earnings Yield | -43.87% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |